-
Nothing but TimeA father with metastatic kidney cancer embraces moments with his 3-year-old son while pondering how he'll be remembered.
by Adam P. Stern
-
When Cancer Becomes an Unwanted PriorityAmanda Rose Ferraro's leukemia diagnosis forced her to spend time at the hospital away from her 3-year-old-son. She calls focusing on her health and leaving her son “the hardest thing I have ever had to do.”
by Amanda Rose Ferraro
-
“Congrats! You Have the ‘Good’ Cancer”Many people know thyroid cancer as a cancer type with a relatively good prognosis, but the disease still has profound effects on patients and survivors, writes thyroid cancer survivor Carly Flumer.
by Carly Flumer
-
Finding Support in Unlikely PlacesAfter her diagnosis with ovarian cancer, Patricia Anne Ward noticed that some friends and family pulled away. She found connection outside her usual circles.
by Patricia Anne Ward
-
A Researcher Attends a Conference, This Time as a Patient AdvocateMy most meaningful moments at my first cancer research conference came from embracing my experience as a patient—not as a researcher.
by Jamie Aten
-
Walking Back From CancerAn American expat in Norway describes how a favorite walking trail aided him during treatment and recovery.
by Steven Ford
-
Coping With TraumaNearly six years after being diagnosed with stage IV colon cancer, disaster psychologist Jamie Aten is still learning new ways of coping with the trauma stemming from his diagnosis and treatment.
by Jamie Aten
-
What Not to Say to a Cancer PatientWhen visiting a friend or family member who is sick, it's good to leave platitudes at the door.
by Michael Gavaghen
-
The Education of a Patient AdvocateBob Riter explains how his breast cancer diagnosis set him on a path to find his calling.
by Bob Riter
-
Learning to ShareAt first, I wanted to hide my cancer diagnosis. My son showed me what a mistake that was.
by Lenn Robbins
Challenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
